...

CPAP, Infant Formula Litigation

by Fadi Agour | Feb 3, 2023

Once again, we attended one of the great webinars put on by Levin Papantonio Rafferty and Mass Torts Made Perfect.

These can be such great sources of information and we thank the presenters for their time and knowledge on these very tricky cases. Even more, they are pushing hard for CLE hours on these webinars, so it’s the epitome of a win-win.

This session was less of a deep dive on one case and more of an update on several, so let’s get to the good stuff.

NEC Baby Formula

Andy Childers, co-Lead attorney of MDL 3026, discussed what has been going on in the NEC baby formula litigation.

The headline here is that direct filing is allowed, and a plaintiff profile form is all that will be required for most cases in the MDL, at least initially.

The only cases where this does not apply are those working in the bellwether process. This will make life easier for plaintiff counsel and the court.

We’re just getting into the bellwether trial process, and discovery for those cases is ongoing. The first bellwether trial is scheduled for March 11, 2024, with most of this year being dedicated to discovery.

The bellwether cases were selected late last year, with four picks for each side, plaintiff and defense, and an additional four random picks made by the court. After fact discovery, plaintiffs and defense will each get to choose two for trial.

These NEC cases are tragic for a number of reasons, making them potentially high value cases.

With easy filing and good science behind it, this may be one of the more exciting cases this year.

CPAP Machine Litigation

Over in the Philips CPAP machine litigation, we’re in a similar situation. The MDL is still ramping up, and we’re in the midst of initial disclosures.

The good news is that general causation is looking great for us. The manufacturers knew that the PE-PUR sound abatement foam was genotoxic and cytotoxic, meaning it was potentially cancer causing, and they did nothing, for years.

Specific causation may be a bit more of a challenge. Troy Bouk of Levin Papantonio Rafferty noted the importance to not only have a solid diagnosis, but also the due diligence to rule out other potential causes.  

In other words, if a plaintiff comes in with a solid lung cancer diagnosis, make sure that they did not work around asbestos or other carcinogenic toxins.

These cases will mostly be based in head, neck and lung cancers, but other diseases like COPD and asthma are also implicated.

Timing is also something to remember – you must file your plaintiff profile form within 45 days of filing the short form complaint in the MDL.

Camp Lejeune

And finally, in Camp Lejeune, we’re dealing more with expectations than reality at this point in time.

As you should know by now, the administrative claims process through Navy JAG gives them a 6-month period to respond, and we’re still inside that window. In other words, the JAG has until February 11, 2023 to respond to the first claims made since passage of the PACT act.

According to Brian Barr, shareholder at Levin Papantonio Rafferty, there have been more than 15,000 claims filed, and not one of them has received an offer to settle.

The JAG has not been completely silent, sometimes asking for additional information, sometimes delivering a Letter of Perfection indicating that the claim submitted was complete. But without a single offer on the table, it looks like these cases will end up needing litigation, at least for now. 

Fees Discussed

Attorney fees in this case were also discussed, with a focus on pending legislation attempting to limit recovery.

There are now three bills being discussed on the subject, and there may be some appetite to resolve the matter through legislation.

While we have nothing to fear as to Senator Sullivan’s absurd limitation of 2% for filing a claim and 10% if it goes to court, the votes may be there to limit attorney fee recovery to 25-33%.

Stay tuned for more on this most important subject.

Plan For Trial

It doesn’t look good for MDL centralization in this case, meaning that we should all plan on trying individual cases if it comes to that.

In the Eastern District of North Carolina, they’re planning for a lot of trial activity, apparently discussing a plan to split the cases amongst judges based on the illness diagnosed.

A lot of this case is still being organized and we’ll have to see what the parties (and the Court) can end up agreeing to.

Excellent Source of Info

These webinars are great. All the above info was covered in an hour if you can believe it. They’re free, and yes, CLE credits may be available.

We know it’s only January and bringing up CLE this early seems strange but imagine a December when you aren’t scrambling for those hours.

We’ll be back with more of these as they come out because they really are great sources of information. If you ever feel like attending, their schedule and the signup form can be found at https://mtmp.com/connect/

Explore More Articles

Why Law Firms Lose the Cases They Already Paid For: 6 Foundation Gaps We See From the Other Side

Marketing agencies write about law firm growth from the outside looking in. We have a different vantage point. Best Case Leads delivers exclusive personal injury leads to law firms across the country, which means we watch the same product, a real injured claimant...

Bicycle Crash Claims: What Personal Injury Firms Need to Know About Liability, Evidence, and Intake

In 2024, 1,103 cyclists were killed and an estimated 52,887 were injured in U.S. traffic crashes, according to the National Highway Traffic Safety Administration. For plaintiff firms, those crashes produce some of the most serious injuries in the motor vehicle docket...

The Jealous Mistress Was Always a Bad Business Model: A Growth Framework for Solo and Small Personal Injury Firms

The Jealous Mistress Was Always a Bad Business Model: A Growth Framework for Solo and Small Personal Injury Firms Justice Story's line about the law demanding "lavish homage" has been quoted to every law student for two centuries. It produced a profession with...

Nearly Half of Law Firms Cannot Be Reached by Phone. The Problem Is Not Marketing. It Is the Empty Chair Next to the Owner.

In 2024, Clio commissioned a secret-shopper study of American law firms. Researchers posed as prospective clients and contacted 500 firms by phone and email. The results, published in the 2024 Legal Trends Report, were unambiguous. Only 40 percent of firms answered...

The Trial Lawyer Who Never Tries a Case: How to Grow a Personal Injury Firm Without Losing the Only Leverage That Matters

In 1990, federal district courts completed 4,765 civil jury trials. In 2025, according to the Administrative Office of the U.S. Courts, they completed 1,048, a decline of 10 percent in a single year and roughly 78 percent over the generation. The state courts, where...

Best Case Leads Celebrates Sixth Consecutive Year on Inc. 5000 List of Fastest-Growing Private Companies in America

Aug 19, 2025 | Press Releases Houston, TX, August 18, 2025 — Best Case Leads, a pioneering leader in legal lead generation, proudly announces its sixth consecutive recognition on the prestigious Inc. 5000 fastest-growing private companies in America, securing...

Baby Formula Litigation, NEC Claims, and the Evolving Landscape of Mass Torts

By Fadi Agour, J.D. Families of premature infants who developed necrotizing enterocolitis (NEC) after being fed cow–milk–based formula products like Similac and Enfamil continue to pursue justice in both state and federal courts. Recent...

Mass Tort Landscape 2025: Key Cases, Trends & Strategic Opportunities

The mass tort landscape is evolving rapidly, with new cases gaining momentum and established litigations reaching critical phases. For law firms and legal marketers, timing is everything—success hinges on anticipating trends, securing high-value claimants early, and...

Zyprexa & Risperdal 2: The Breast Cancer Link That Could Ignite the Next Mass Tort

The pharmaceutical litigation landscape has seen its share of blockbuster cases—from opioid multidistrict litigations to the ongoing Paraquat Parkinson’s claims. But a new California lawsuit (Brown v. Johnson & Johnson et al.) could revive two legacy antipsychotics...

Mass Torts in 2025: A Legal Landscape in Flux

As 2025 unfolds, the world of mass tort litigation shows no signs of slowing down. From pharmaceutical giants to tech behemoths, corporations across industries are facing an unprecedented wave of lawsuits that could reshape their futures. With judges issuing critical...